Rock Springs Capital Management LP - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 45 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$816,000
-32.2%
150,000
-62.5%
0.03%
-45.8%
Q3 2019$1,204,000
-19.5%
400,0000.0%0.05%
-11.1%
Q2 2019$1,496,000
-7.0%
400,0000.0%0.05%
-12.9%
Q1 2019$1,608,000
+9.5%
400,0000.0%0.06%
-10.1%
Q4 2018$1,468,000
-70.2%
400,000
-30.4%
0.07%
-61.5%
Q3 2018$4,934,000
-21.9%
575,0000.0%0.18%
-26.3%
Q2 2018$6,314,000
-4.8%
575,0000.0%0.24%
-14.1%
Q1 2018$6,630,000
+51.4%
575,000
+36.1%
0.28%
+42.2%
Q4 2017$4,378,000
-35.0%
422,6000.0%0.20%
-36.0%
Q3 2017$6,736,000
+31.7%
422,6000.0%0.31%
+20.5%
Q2 2017$5,113,000
-41.7%
422,6000.0%0.26%
-49.0%
Q1 2017$8,777,000
+36.4%
422,600
-6.1%
0.51%
+17.4%
Q4 2016$6,435,000
-13.1%
450,0000.0%0.43%
-7.1%
Q3 2016$7,403,000
+15.4%
450,0000.0%0.46%
-2.3%
Q2 2016$6,417,000
-3.1%
450,000
-1.5%
0.48%
-14.4%
Q1 2016$6,625,000456,8870.56%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$28,105,0004.42%
Novo Holdings A/S 4,420,516$37,928,0003.01%
BVF INC/IL 1,890,507$16,221,0001.42%
Orbimed Advisors 5,967,584$51,202,0000.62%
COWEN INC. 588,706$5,051,0000.46%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 108,000$710,0000.34%
SPHERA FUNDS MANAGEMENT LTD. 321,430$2,758,0000.32%
EcoR1 Capital, LLC 351,401$3,015,0000.27%
Rock Springs Capital Management LP 575,000$4,934,0000.18%
Hikari Power Ltd 32,090$275,0000.03%
View complete list of CORVUS PHARMACEUTICALS INC shareholders